(Total Views: 387)
Posted On: 04/02/2020 9:56:32 AM
Post# of 36519
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Paul Jackson #14935
What is bad about that Forbes article is GNBT is listed within the EpiVax blurb. It should be the other way around! I get the feeling that EpiVax is trying to bask itself in publicity but they are just a bit player compared to GNBT.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)